In the last 12 months, insiders at GILEAD SCIENCES, INC. ($GILD) filed 646 transactions with the SEC: 16 open-market purchases totaling $367,642,523 and 101 sales totaling $159,644,573. Net insider sentiment: net buying.
GILEAD SCIENCES, INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- GILEAD SCIENCES, INC. (TenPercentOwner) — 16 transactions totaling $367,642,523
- Dickinson Andrew D (Chief Financial Officer) — 125 transactions totaling $111,244,434
- O'Day Daniel Patrick (Chairman & CEO) — 92 transactions totaling $103,171,007
- Parsey Merdad (Chief Medical Officer) — 65 transactions totaling $39,073,321
- Mercier Johanna (Chief Commercial Officer) — 95 transactions totaling $32,031,517
View all SEC Filings for GILEAD SCIENCES, INC. (GILD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 10000 | $136.82 | 642,567.0000 | 1,256,000,000 | 1.53% | 0.00% |
| March 16, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 3000 | $144.23 | 131,779.0000 | 1,256,000,000 | 2.23% | 0.00% |
| March 16, 2026 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $144.23 | 179,191.0000 | 1,256,000,000 | 1.65% | 0.00% |
| March 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | A | Restricted Stock Unit | 5050 | $0.00 | 20,586.0000 | 1,256,000,000 | 32.51% | 0.00% |
| March 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | A | Non-qualified Stock Option (Right to Buy) | 18885 | $0.00 | 18,885.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | Burkhart Erin | SVP, Controllership | A | Restricted Stock Unit | 2355 | $0.00 | 11,245.0000 | 1,256,000,000 | 26.49% | 0.00% |
| March 10, 2026 | Burkhart Erin | SVP, Controllership | A | Non-qualified Stock Option (Right to Buy) | 5455 | $0.00 | 5,455.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 20026 | $0.00 | 662,334.0000 | 1,256,000,000 | 3.12% | 0.00% |
| March 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 9767 | $148.56 | 652,567.0000 | 1,256,000,000 | 1.47% | 0.00% |
| March 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 20026 | $0.00 | 68,044.0000 | 1,256,000,000 | 22.74% | 0.00% |
| March 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | A | Restricted Stock Unit | 32815 | $0.00 | 100,859.0000 | 1,256,000,000 | 48.23% | 0.00% |
| March 10, 2026 | O'Day Daniel Patrick | Chairman & CEO | A | Non-qualified Stock Option (Right to Buy) | 122755 | $0.00 | 122,755.0000 | 1,256,000,000 | 9999.99% | 0.01% |
| March 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | M | Common Stock | 1246 | $0.00 | 5,660.0000 | 1,256,000,000 | 28.23% | 0.00% |
| March 10, 2026 | Berger Dietmar | Chief Medical Officer | F | Common Stock | 1063 | $148.56 | 18,982.0000 | 1,256,000,000 | 5.30% | 0.00% |
| March 10, 2026 | Berger Dietmar | Chief Medical Officer | M | Restricted Stock Unit | 2133 | $0.00 | 39,046.0000 | 1,256,000,000 | 5.18% | 0.00% |
| March 10, 2026 | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 8415 | $0.00 | 47,461.0000 | 1,256,000,000 | 21.55% | 0.00% |
| March 10, 2026 | Berger Dietmar | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 31475 | $0.00 | 31,475.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 6469 | $0.00 | 185,338.0000 | 1,256,000,000 | 3.62% | 0.00% |
| March 10, 2026 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 3147 | $148.56 | 182,191.0000 | 1,256,000,000 | 1.70% | 0.00% |
| March 10, 2026 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 6469 | $0.00 | 21,057.0000 | 1,256,000,000 | 23.50% | 0.00% |
| March 10, 2026 | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 9590 | $0.00 | 30,647.0000 | 1,256,000,000 | 45.54% | 0.00% |
| March 10, 2026 | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 35880 | $0.00 | 35,880.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Non-qualified Stock Option (Right to Buy) | 35880 | $0.00 | 35,880.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Restricted Stock Unit | 9590 | $0.00 | 30,647.0000 | 1,256,000,000 | 45.54% | 0.00% |
| March 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Restricted Stock Unit | 6617 | $0.00 | 21,057.0000 | 1,256,000,000 | 23.91% | 0.00% |
| March 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | F | Common Stock | 3216 | $148.56 | 134,779.0000 | 1,256,000,000 | 2.33% | 0.00% |
| March 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Common Stock | 6617 | $0.00 | 137,995.0000 | 1,256,000,000 | 5.04% | 0.00% |
| March 10, 2026 | Berger Dietmar | Chief Medical Officer | M | Common Stock | 2133 | $0.00 | 20,045.0000 | 1,256,000,000 | 11.91% | 0.00% |
| March 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | F | Common Stock | 606 | $148.56 | 5,054.0000 | 1,256,000,000 | 10.71% | 0.00% |
| March 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | M | Restricted Stock Unit | 1246 | $0.00 | 15,536.0000 | 1,256,000,000 | 7.42% | 0.00% |
| Feb. 27, 2026 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 11090 | $0.00 | 178,869.0000 | 1,256,000,000 | 6.61% | 0.00% |
| Feb. 27, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 100 | $145.71 | 642,308.0000 | 1,256,000,000 | 0.02% | 0.00% |
| Feb. 27, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 6419 | $145.18 | 642,408.0000 | 1,256,000,000 | 0.99% | 0.00% |
| Feb. 27, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 3481 | $144.04 | 648,827.0000 | 1,256,000,000 | 0.53% | 0.00% |
| Feb. 27, 2026 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 38396 | $0.00 | 652,308.0000 | 1,256,000,000 | 6.25% | 0.00% |
| Feb. 27, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | A | Common Stock | 470 | $0.00 | 4,414.0000 | 1,256,000,000 | 11.92% | 0.00% |
| Feb. 27, 2026 | Berger Dietmar | Chief Medical Officer | A | Common Stock | 8530 | $0.00 | 17,912.0000 | 1,256,000,000 | 90.92% | 0.00% |
| Feb. 27, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Common Stock | 11090 | $0.00 | 131,378.0000 | 1,256,000,000 | 9.22% | 0.00% |
| Feb. 17, 2026 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $154.43 | 167,779.0000 | 1,256,000,000 | 1.76% | 0.00% |
| Feb. 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 48,110.0000 | 1,256,000,000 | 34.20% | 0.00% |
| Feb. 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 200 | $155.62 | 120,288.0000 | 1,256,000,000 | 0.17% | 0.00% |
| Feb. 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 9395 | $154.91 | 120,488.0000 | 1,256,000,000 | 7.23% | 0.00% |
| Feb. 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 18405 | $154.18 | 129,883.0000 | 1,256,000,000 | 12.41% | 0.00% |
| Feb. 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Common Stock | 25000 | $66.64 | 148,288.0000 | 1,256,000,000 | 20.28% | 0.00% |
| Feb. 13, 2026 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 3739000 | $0.53 | 40,384,266.0000 | 1,256,000,000 | 10.20% | 0.30% |
| Feb. 5, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Non-qualified Stock Option (Right to Buy) | 115640 | $0.00 | 0.0000 | 1,256,000,000 | 100.00% | 0.01% |
| Feb. 5, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 115640 | $150.00 | 613,912.0000 | 1,256,000,000 | 15.85% | 0.01% |
| Feb. 5, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 115640 | $66.01 | 729,552.0000 | 1,256,000,000 | 18.84% | 0.01% |
| Feb. 3, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | F | Common Stock | 24800 | $143.28 | 123,288.0000 | 1,256,000,000 | 16.75% | 0.00% |
| Feb. 3, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Common Stock | 44867 | $0.00 | 148,088.0000 | 1,256,000,000 | 43.47% | 0.00% |
| Feb. 3, 2026 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 44867 | $0.00 | 195,370.0000 | 1,256,000,000 | 29.81% | 0.00% |
| Feb. 3, 2026 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 24802 | $143.28 | 170,568.0000 | 1,256,000,000 | 12.69% | 0.00% |
| Feb. 3, 2026 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 131675 | $0.00 | 688,373.0000 | 1,256,000,000 | 23.65% | 0.01% |
| Feb. 3, 2026 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 74461 | $143.28 | 613,912.0000 | 1,256,000,000 | 10.82% | 0.01% |
| Jan. 28, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 4968 | $140.24 | 556,698.0000 | 1,256,000,000 | 0.88% | 0.00% |
| Jan. 28, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 5032 | $139.54 | 561,666.0000 | 1,256,000,000 | 0.89% | 0.00% |
| Jan. 23, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Non-qualified Stock Option (Right to Buy) | 115640 | $0.00 | 115,640.0000 | 1,256,000,000 | 50.00% | 0.01% |
| Jan. 23, 2026 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 115640 | $66.01 | 682,338.0000 | 1,256,000,000 | 20.41% | 0.01% |
| Jan. 23, 2026 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 115640 | $135.00 | 566,698.0000 | 1,256,000,000 | 16.95% | 0.01% |
| Jan. 20, 2026 | Bluestone Jeffrey | Director | S | Common Stock | 5000 | $123.50 | 8,920.0000 | 1,256,000,000 | 35.92% | 0.00% |
| Jan. 20, 2026 | Bluestone Jeffrey | Director | M | Non-qualified Stock Option (Right to Buy) | 5000 | $0.00 | 4,665.0000 | 1,256,000,000 | 51.73% | 0.00% |
| Jan. 20, 2026 | Bluestone Jeffrey | Director | M | Common Stock | 5000 | $67.45 | 13,920.0000 | 1,256,000,000 | 56.05% | 0.00% |
| Jan. 15, 2026 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $124.31 | 150,503.0000 | 1,256,000,000 | 1.95% | 0.00% |
| Jan. 15, 2026 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $124.31 | 103,221.0000 | 1,256,000,000 | 2.82% | 0.00% |
| Jan. 2, 2026 | Berger Dietmar | Chief Medical Officer | M | Common Stock | 16326 | $0.00 | 16,326.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Berger Dietmar | Chief Medical Officer | M | Restricted Stock Unit | 16326 | $0.00 | 41,179.0000 | 1,256,000,000 | 28.39% | 0.00% |
| Jan. 2, 2026 | Berger Dietmar | Chief Medical Officer | F | Common Stock | 6944 | $121.60 | 9,382.0000 | 1,256,000,000 | 42.53% | 0.00% |
| Dec. 29, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 10000 | $124.83 | 566,698.0000 | 1,256,000,000 | 1.73% | 0.00% |
| Dec. 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 3000 | $122.00 | 153,503.0000 | 1,256,000,000 | 1.92% | 0.00% |
| Dec. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $122.00 | 106,221.0000 | 1,256,000,000 | 2.75% | 0.00% |
| Dec. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3693 | $0.00 | 27,526.0000 | 1,256,000,000 | 11.83% | 0.00% |
| Dec. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1745 | $121.34 | 156,503.0000 | 1,256,000,000 | 1.10% | 0.00% |
| Dec. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3693 | $0.00 | 158,248.0000 | 1,256,000,000 | 2.39% | 0.00% |
| Dec. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10426 | $0.00 | 88,070.0000 | 1,256,000,000 | 10.59% | 0.00% |
| Dec. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4931 | $121.34 | 576,698.0000 | 1,256,000,000 | 0.85% | 0.00% |
| Dec. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10426 | $0.00 | 581,629.0000 | 1,256,000,000 | 1.83% | 0.00% |
| Dec. 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3842 | $0.00 | 27,674.0000 | 1,256,000,000 | 12.19% | 0.00% |
| Dec. 10, 2025 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1814 | $121.34 | 109,221.0000 | 1,256,000,000 | 1.63% | 0.00% |
| Dec. 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3842 | $0.00 | 111,035.0000 | 1,256,000,000 | 3.58% | 0.00% |
| Nov. 28, 2025 | Kramer Kelly A. | Director | M | Common Stock | 2805 | $81.00 | 4,144.0000 | 1,256,000,000 | 209.48% | 0.00% |
| Nov. 28, 2025 | Bluestone Jeffrey | Director | M | Non-qualified Stock Option (Right to Buy) | 5000 | $0.00 | 7,648.0000 | 1,256,000,000 | 39.53% | 0.00% |
| Nov. 28, 2025 | Bluestone Jeffrey | Director | S | Common Stock | 5000 | $125.08 | 8,920.0000 | 1,256,000,000 | 35.92% | 0.00% |
| Nov. 28, 2025 | Bluestone Jeffrey | Director | M | Common Stock | 5000 | $64.92 | 13,920.0000 | 1,256,000,000 | 56.05% | 0.00% |
| Nov. 28, 2025 | Kramer Kelly A. | Director | M | Non-qualified Stock Option (Right to Buy) | 2805 | $0.00 | 0.0000 | 1,256,000,000 | 100.00% | 0.00% |
| Nov. 26, 2025 | Kramer Kelly A. | Director | M | Non-qualified Stock Option (Right to Buy) | 2806 | $0.00 | 2,805.0000 | 1,256,000,000 | 50.01% | 0.00% |
| Nov. 28, 2025 | Kramer Kelly A. | Director | S | Common Stock | 2805 | $127.10 | 1,339.0000 | 1,256,000,000 | 67.69% | 0.00% |
| Nov. 26, 2025 | Kramer Kelly A. | Director | S | Common Stock | 2806 | $127.11 | 1,339.0000 | 1,256,000,000 | 67.70% | 0.00% |
| Nov. 26, 2025 | Kramer Kelly A. | Director | M | Common Stock | 2806 | $81.00 | 4,145.0000 | 1,256,000,000 | 209.56% | 0.00% |
| Nov. 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 6788 | $126.84 | 571,203.0000 | 1,256,000,000 | 1.17% | 0.00% |
| Nov. 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 3212 | $125.91 | 577,991.0000 | 1,256,000,000 | 0.55% | 0.00% |
| Nov. 17, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $125.23 | 154,555.0000 | 1,256,000,000 | 1.59% | 0.00% |
| Nov. 17, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 73,110.0000 | 1,256,000,000 | 25.48% | 0.00% |
| Nov. 17, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 2476 | $126.26 | 107,193.0000 | 1,256,000,000 | 2.26% | 0.00% |
| Nov. 17, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 25524 | $125.83 | 109,669.0000 | 1,256,000,000 | 18.88% | 0.00% |
| Nov. 17, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 25000 | $66.64 | 135,193.0000 | 1,256,000,000 | 22.69% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 500 | $0.00 | 12,155.0000 | 1,256,000,000 | 3.95% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 35965 | $0.00 | 12,655.0000 | 1,256,000,000 | 73.97% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 17181 | $0.00 | 37,799.0000 | 1,256,000,000 | 31.25% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 500 | $122.90 | 43,676.0000 | 1,256,000,000 | 1.13% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 35965 | $60.75 | 79,641.0000 | 1,256,000,000 | 82.34% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 17181 | $75.12 | 60,857.0000 | 1,256,000,000 | 39.34% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 500 | $60.75 | 44,176.0000 | 1,256,000,000 | 1.14% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 17181 | $124.00 | 43,676.0000 | 1,256,000,000 | 28.23% | 0.00% |
| Nov. 12, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 35965 | $122.30 | 43,676.0000 | 1,256,000,000 | 45.16% | 0.00% |
| Oct. 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 7978 | $119.54 | 583,225.0000 | 1,256,000,000 | 1.35% | 0.00% |
| Oct. 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 2022 | $118.82 | 581,203.0000 | 1,256,000,000 | 0.35% | 0.00% |
| Oct. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 43,917.0000 | 1,256,000,000 | 1.19% | 0.00% |
| Oct. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 19,816.0000 | 1,256,000,000 | 2.53% | 0.00% |
| Oct. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 241 | $120.94 | 43,676.0000 | 1,256,000,000 | 0.55% | 0.00% |
| Oct. 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $118.08 | 157,055.0000 | 1,256,000,000 | 1.57% | 0.00% |
| Oct. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $118.08 | 110,193.0000 | 1,256,000,000 | 2.65% | 0.00% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Class B warrants to purchase Common Stock | 1147960 | $0.00 | 1,147,960.0000 | 1,255,000,000 | 9999.99% | 0.09% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 2295920 | $0.00 | 4,505,391.0000 | 1,255,000,000 | 103.91% | 0.18% |
| Aug. 8, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Class A warrants to purchase Common Stock | 1147960 | $0.00 | 1,147,960.0000 | 1,255,000,000 | 9999.99% | 0.09% |
| Sept. 29, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 1961 | $112.42 | 591,203.0000 | 1,255,000,000 | 0.33% | 0.00% |
| Sept. 29, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 8039 | $111.47 | 593,164.0000 | 1,255,000,000 | 1.34% | 0.00% |
| Sept. 22, 2025 | Burkhart Erin | SVP, Controllership | A | Restricted Stock Unit | 8890 | $0.00 | 8,890.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| Sept. 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $113.57 | 159,555.0000 | 1,255,000,000 | 1.54% | 0.00% |
| Sept. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $113.57 | 113,193.0000 | 1,255,000,000 | 2.58% | 0.00% |
| Sept. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3696 | $0.00 | 31,219.0000 | 1,255,000,000 | 10.59% | 0.00% |
| Sept. 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | F | Common Stock | 338 | $115.25 | 46,259.0000 | 1,255,000,000 | 0.73% | 0.00% |
| Sept. 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | M | Restricted Stock Unit | 921 | $0.00 | 7,864.0000 | 1,255,000,000 | 10.48% | 0.00% |
| Sept. 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 1315 | $0.00 | 44,036.0000 | 1,255,000,000 | 3.08% | 0.00% |
| Sept. 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 634 | $115.25 | 43,402.0000 | 1,255,000,000 | 1.44% | 0.00% |
| Sept. 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 1315 | $0.00 | 20,331.0000 | 1,255,000,000 | 6.08% | 0.00% |
| Sept. 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3844 | $0.00 | 118,012.0000 | 1,255,000,000 | 3.37% | 0.00% |
| Sept. 10, 2025 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1819 | $115.25 | 116,193.0000 | 1,255,000,000 | 1.54% | 0.00% |
| Sept. 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3844 | $0.00 | 31,516.0000 | 1,255,000,000 | 10.87% | 0.00% |
| Sept. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3696 | $0.00 | 163,806.0000 | 1,255,000,000 | 2.31% | 0.00% |
| Sept. 10, 2025 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1751 | $115.25 | 162,055.0000 | 1,255,000,000 | 1.07% | 0.00% |
| Sept. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10427 | $0.00 | 98,496.0000 | 1,255,000,000 | 9.57% | 0.00% |
| Sept. 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | M | Common Stock | 921 | $0.00 | 46,597.0000 | 1,255,000,000 | 2.02% | 0.00% |
| Sept. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4949 | $115.25 | 601,203.0000 | 1,255,000,000 | 0.82% | 0.00% |
| Sept. 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10427 | $0.00 | 606,152.0000 | 1,255,000,000 | 1.75% | 0.00% |
| Aug. 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 10000 | $113.63 | 595,725.0000 | 1,255,000,000 | 1.65% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 11800 | $118.50 | 117,168.0000 | 1,255,000,000 | 9.15% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 11800 | $66.64 | 128,968.0000 | 1,255,000,000 | 10.07% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 700 | $66.64 | 117,868.0000 | 1,255,000,000 | 0.60% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 700 | $118.97 | 117,168.0000 | 1,255,000,000 | 0.59% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 11800 | $66.64 | 128,968.0000 | 1,255,000,000 | 10.07% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 11800 | $118.51 | 117,168.0000 | 1,255,000,000 | 9.15% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 700 | $66.64 | 117,868.0000 | 1,255,000,000 | 0.60% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 700 | $118.97 | 117,168.0000 | 1,255,000,000 | 0.59% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 2800 | $118.51 | 114,368.0000 | 1,255,000,000 | 2.39% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 200 | $118.97 | 114,168.0000 | 1,255,000,000 | 0.17% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 11800 | $0.00 | 111,310.0000 | 1,255,000,000 | 9.58% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 700 | $0.00 | 110,610.0000 | 1,255,000,000 | 0.63% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 11800 | $0.00 | 98,810.0000 | 1,255,000,000 | 10.67% | 0.00% |
| Aug. 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $118.53 | 160,110.0000 | 1,255,000,000 | 1.54% | 0.00% |
| Aug. 15, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 700 | $0.00 | 98,110.0000 | 1,255,000,000 | 0.71% | 0.00% |
| July 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 1655 | $113.17 | 614,070.0000 | 1,255,000,000 | 0.27% | 0.00% |
| July 28, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 8345 | $114.09 | 605,725.0000 | 1,255,000,000 | 1.36% | 0.00% |
| July 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 38,315.0000 | 1,255,000,000 | 1.36% | 0.00% |
| July 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 3823 | $116.20 | 42,721.0000 | 1,255,000,000 | 8.21% | 0.00% |
| July 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 29,875.0000 | 1,255,000,000 | 1.69% | 0.00% |
| July 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8229 | $0.00 | 21,646.0000 | 1,255,000,000 | 27.54% | 0.00% |
| July 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8229 | $0.00 | 46,544.0000 | 1,255,000,000 | 21.48% | 0.00% |
| July 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $111.03 | 162,610.0000 | 1,255,000,000 | 1.51% | 0.00% |
| July 15, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $111.03 | 117,168.0000 | 1,255,000,000 | 2.50% | 0.00% |
| July 14, 2025 | Bluestone Jeffrey | Director | M | Common Stock | 5000 | $67.45 | 13,920.0000 | 1,255,000,000 | 56.05% | 0.00% |
| July 14, 2025 | Bluestone Jeffrey | Director | S | Common Stock | 5000 | $109.74 | 8,920.0000 | 1,255,000,000 | 35.92% | 0.00% |
| July 14, 2025 | Bluestone Jeffrey | Director | M | Non-qualified Stock Option (Right to Buy) | 5000 | $0.00 | 9,665.0000 | 1,255,000,000 | 34.09% | 0.00% |
| June 30, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 9400 | $110.40 | 616,325.0000 | 1,255,000,000 | 1.50% | 0.00% |
| June 30, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 600 | $111.15 | 615,725.0000 | 1,255,000,000 | 0.10% | 0.00% |
| June 16, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $110.17 | 165,110.0000 | 1,255,000,000 | 1.49% | 0.00% |
| June 16, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $110.17 | 120,168.0000 | 1,255,000,000 | 2.44% | 0.00% |
| June 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3843 | $0.00 | 124,995.0000 | 1,255,000,000 | 3.17% | 0.00% |
| June 10, 2025 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1827 | $110.09 | 123,168.0000 | 1,255,000,000 | 1.46% | 0.00% |
| June 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3843 | $0.00 | 35,360.0000 | 1,255,000,000 | 9.80% | 0.00% |
| June 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10425 | $0.00 | 630,693.0000 | 1,255,000,000 | 1.68% | 0.00% |
| June 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4968 | $110.09 | 625,725.0000 | 1,255,000,000 | 0.79% | 0.00% |
| June 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10425 | $0.00 | 108,923.0000 | 1,255,000,000 | 8.73% | 0.00% |
| June 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3694 | $0.00 | 169,368.0000 | 1,255,000,000 | 2.23% | 0.00% |
| June 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3694 | $0.00 | 34,915.0000 | 1,255,000,000 | 9.57% | 0.00% |
| June 10, 2025 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1758 | $110.09 | 167,610.0000 | 1,255,000,000 | 1.04% | 0.00% |
| June 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | M | Common Stock | 920 | $0.00 | 46,016.0000 | 1,255,000,000 | 2.04% | 0.00% |
| June 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | F | Common Stock | 340 | $110.09 | 45,676.0000 | 1,255,000,000 | 0.74% | 0.00% |
| June 10, 2025 | Wilfong Diane E. | Interim Corp Controller & CAO | M | Restricted Stock Unit | 920 | $0.00 | 8,785.0000 | 1,255,000,000 | 9.48% | 0.00% |
| June 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 1313 | $0.00 | 38,231.0000 | 1,255,000,000 | 3.56% | 0.00% |
| June 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 430 | $110.09 | 37,801.0000 | 1,255,000,000 | 1.12% | 0.00% |
| June 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 1313 | $0.00 | 30,389.0000 | 1,255,000,000 | 4.14% | 0.00% |
| June 5, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series C Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 13335000 | $0.00 | 23,310,266.0000 | 1,255,000,000 | 133.68% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series A Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| June 5, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Series B Warrants (right to buy) | 13335000 | $0.00 | 13,335,000.0000 | 1,255,000,000 | 9999.99% | 1.06% |
| May 30, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 3584 | $110.96 | 620,268.0000 | 1,255,000,000 | 0.57% | 0.00% |
| May 30, 2025 | O'Day Daniel Patrick | Chairman & CEO | S | Common Stock | 6416 | $110.11 | 623,852.0000 | 1,255,000,000 | 1.02% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 12500 | $0.00 | 123,110.0000 | 1,255,000,000 | 9.22% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 12500 | $107.52 | 124,152.0000 | 1,255,000,000 | 9.15% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 12500 | $0.00 | 135,610.0000 | 1,255,000,000 | 8.44% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $107.52 | 121,152.0000 | 1,255,000,000 | 2.42% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 12500 | $66.64 | 136,652.0000 | 1,255,000,000 | 10.07% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 12500 | $107.52 | 124,152.0000 | 1,255,000,000 | 9.15% | 0.00% |
| May 22, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 12500 | $66.64 | 136,652.0000 | 1,255,000,000 | 10.07% | 0.00% |
| May 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $99.82 | 165,674.0000 | 1,255,000,000 | 1.49% | 0.00% |
| May 7, 2025 | WELTERS ANTHONY | Director | A | Common Stock | 1516 | $0.00 | 11,748.0000 | 1,255,000,000 | 14.82% | 0.00% |
| May 7, 2025 | WELTERS ANTHONY | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | Rodriguez Javier | Director | A | Common Stock | 1516 | $0.00 | 12,218.0000 | 1,255,000,000 | 14.17% | 0.00% |
| May 7, 2025 | Rodriguez Javier | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | LOVE TED W | Director | A | Common Stock | 1516 | $0.00 | 4,338.0000 | 1,255,000,000 | 53.72% | 0.00% |
| May 7, 2025 | LOVE TED W | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | BARTON JACQUELINE K | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | BARTON JACQUELINE K | Director | A | Common Stock | 1516 | $0.00 | 26,056.0000 | 1,255,000,000 | 6.18% | 0.00% |
| May 7, 2025 | Horning Sandra | Director | A | Common Stock | 1516 | $0.00 | 5,147.0000 | 1,255,000,000 | 41.75% | 0.00% |
| May 7, 2025 | Horning Sandra | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | MANWANI HARISH | Director | A | Common Stock | 1516 | $0.00 | 14,389.0000 | 1,255,000,000 | 11.78% | 0.00% |
| May 7, 2025 | MANWANI HARISH | Director | F | Common Stock | 296 | $98.90 | 14,093.0000 | 1,255,000,000 | 2.06% | 0.00% |
| May 7, 2025 | MANWANI HARISH | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | Kramer Kelly A. | Director | A | Restricted Stock Unit | 1516 | $0.00 | 19,110.0000 | 1,255,000,000 | 8.62% | 0.00% |
| May 7, 2025 | Kramer Kelly A. | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| May 7, 2025 | Bluestone Jeffrey | Director | A | Restricted Stock Unit | 1516 | $0.00 | 5,713.0000 | 1,255,000,000 | 36.12% | 0.00% |
| May 7, 2025 | Bluestone Jeffrey | Director | A | Non-qualified Stock Option (Right to Buy) | 6809 | $0.00 | 6,809.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| April 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 158 | $103.17 | 36,918.0000 | 1,255,000,000 | 0.43% | 0.00% |
| April 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 37,076.0000 | 1,255,000,000 | 1.41% | 0.00% |
| April 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 31,702.0000 | 1,255,000,000 | 1.60% | 0.00% |
| April 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $106.40 | 168,174.0000 | 1,255,000,000 | 1.46% | 0.00% |
| March 17, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $110.53 | 170,674.0000 | 1,255,000,000 | 1.44% | 0.00% |
| March 10, 2025 | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 49020 | $0.00 | 49,020.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 11090 | $0.00 | 39,203.0000 | 1,255,000,000 | 39.45% | 0.00% |
| March 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 24024 | $0.00 | 641,900.0000 | 1,255,000,000 | 3.89% | 0.00% |
| March 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 11632 | $117.21 | 630,268.0000 | 1,255,000,000 | 1.81% | 0.00% |
| March 10, 2025 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 3907 | $117.21 | 124,152.0000 | 1,255,000,000 | 3.05% | 0.00% |
| March 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 8080 | $0.00 | 28,113.0000 | 1,255,000,000 | 22.32% | 0.00% |
| March 10, 2025 | Berger Dietmar | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 37710 | $0.00 | 37,710.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 8080 | $0.00 | 128,059.0000 | 1,255,000,000 | 6.73% | 0.00% |
| March 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 24024 | $0.00 | 80,953.0000 | 1,255,000,000 | 22.89% | 0.00% |
| March 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | A | Non-qualified Stock Option (Right to Buy) | 169690 | $0.00 | 169,690.0000 | 1,255,000,000 | 9999.99% | 0.01% |
| March 10, 2025 | O'Day Daniel Patrick | Chairman & CEO | A | Restricted Stock Unit | 38395 | $0.00 | 119,348.0000 | 1,255,000,000 | 47.43% | 0.00% |
| March 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 3343 | $0.00 | 37,692.0000 | 1,255,000,000 | 9.73% | 0.00% |
| March 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 1130 | $117.21 | 36,562.0000 | 1,255,000,000 | 3.00% | 0.00% |
| March 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 3343 | $0.00 | 24,356.0000 | 1,255,000,000 | 12.07% | 0.00% |
| March 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 33940 | $0.00 | 33,940.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 7680 | $0.00 | 32,216.0000 | 1,255,000,000 | 31.30% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 4916 | $63.91 | 173,977.0000 | 1,255,000,000 | 2.91% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 13013 | $63.91 | 186,990.0000 | 1,255,000,000 | 7.48% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 4916 | $117.30 | 182,074.0000 | 1,255,000,000 | 2.63% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 13013 | $118.50 | 169,061.0000 | 1,255,000,000 | 7.15% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 7968 | $0.00 | 177,029.0000 | 1,255,000,000 | 4.71% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 3855 | $117.21 | 173,174.0000 | 1,255,000,000 | 2.18% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 4916 | $0.00 | 13,013.0000 | 1,255,000,000 | 27.42% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 13013 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 7968 | $0.00 | 27,519.0000 | 1,255,000,000 | 22.45% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 49020 | $0.00 | 49,020.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 11090 | $0.00 | 38,609.0000 | 1,255,000,000 | 40.30% | 0.00% |
| March 10, 2025 | Patterson Sandra | SVP, Controllership | M | Common Stock | 1952 | $0.00 | 40,077.0000 | 1,255,000,000 | 5.12% | 0.00% |
| March 10, 2025 | Patterson Sandra | SVP, Controllership | F | Common Stock | 624 | $117.21 | 39,453.0000 | 1,255,000,000 | 1.56% | 0.00% |
| March 10, 2025 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 1952 | $0.00 | 9,875.0000 | 1,255,000,000 | 16.50% | 0.00% |
| March 10, 2025 | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 8530 | $0.00 | 57,505.0000 | 1,255,000,000 | 17.42% | 0.00% |
| Feb. 18, 2025 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1363636 | $11.00 | 31,424,760.0000 | 1,255,000,000 | 4.54% | 0.11% |
| Feb. 18, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $104.09 | 169,061.0000 | 1,255,000,000 | 1.46% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26175 | $0.00 | 78,515.0000 | 1,255,000,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 18210 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 15600 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 77691 | $0.00 | 17,929.0000 | 1,255,000,000 | 81.25% | 0.01% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 137676 | $102.22 | 171,223.0000 | 1,255,000,000 | 44.57% | 0.01% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 18210 | $83.49 | 308,899.0000 | 1,255,000,000 | 6.26% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 15600 | $80.72 | 290,689.0000 | 1,255,000,000 | 5.67% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26175 | $57.92 | 275,089.0000 | 1,255,000,000 | 10.52% | 0.00% |
| Feb. 12, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 77691 | $63.91 | 248,914.0000 | 1,255,000,000 | 45.37% | 0.01% |
| Feb. 4, 2025 | Patterson Sandra | SVP, Controllership | A | Common Stock | 709 | $0.00 | 37,787.0000 | 1,255,000,000 | 1.91% | 0.00% |
| Feb. 4, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 12371 | $0.00 | 34,011.0000 | 1,255,000,000 | 57.17% | 0.00% |
| Feb. 4, 2025 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 60031 | $0.00 | 561,559.0000 | 1,255,000,000 | 11.97% | 0.00% |
| Feb. 4, 2025 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 164473 | $0.00 | 726,032.0000 | 1,255,000,000 | 29.29% | 0.01% |
| Feb. 4, 2025 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 108156 | $97.99 | 617,876.0000 | 1,255,000,000 | 14.90% | 0.01% |
| Feb. 4, 2025 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 19793 | $0.00 | 94,933.0000 | 1,255,000,000 | 26.34% | 0.00% |
| Feb. 4, 2025 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 70712 | $0.00 | 165,645.0000 | 1,255,000,000 | 74.49% | 0.01% |
| Feb. 4, 2025 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 45666 | $97.99 | 119,979.0000 | 1,255,000,000 | 27.57% | 0.00% |
| Feb. 4, 2025 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 19793 | $0.00 | 149,666.0000 | 1,255,000,000 | 15.24% | 0.00% |
| Feb. 4, 2025 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 64695 | $0.00 | 214,361.0000 | 1,255,000,000 | 43.23% | 0.01% |
| Feb. 4, 2025 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 43138 | $97.99 | 171,223.0000 | 1,255,000,000 | 20.12% | 0.00% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26170 | $57.92 | 156,043.0000 | 1,255,000,000 | 20.15% | 0.00% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 71850 | $72.34 | 227,893.0000 | 1,255,000,000 | 46.05% | 0.01% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 44160 | $65.38 | 273,053.0000 | 1,255,000,000 | 19.29% | 0.00% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 142180 | $97.22 | 129,873.0000 | 1,255,000,000 | 52.26% | 0.01% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26170 | $0.00 | 104,690.0000 | 1,255,000,000 | 20.00% | 0.00% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 71850 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.01% |
| Jan. 31, 2025 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 44160 | $0.00 | 0.0000 | 1,255,000,000 | 100.00% | 0.00% |
| Jan. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 21,827.0000 | 1,255,000,000 | 2.42% | 0.00% |
| Jan. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 187 | $93.07 | 21,640.0000 | 1,255,000,000 | 0.86% | 0.00% |
| Jan. 25, 2025 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 27,879.0000 | 1,255,000,000 | 1.81% | 0.00% |
| Jan. 15, 2025 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 2500 | $91.35 | 129,873.0000 | 1,255,000,000 | 1.89% | 0.00% |
| Jan. 2, 2025 | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 48975 | $0.00 | 48,975.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| Dec. 18, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1759978 | $1.04 | 9,105,451.0000 | 1,254,000,000 | 23.96% | 0.14% |
| Dec. 18, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 6092816 | $1.04 | 9,975,266.0000 | 1,254,000,000 | 156.93% | 0.49% |
| Dec. 16, 2024 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 8500 | $91.96 | 132,373.0000 | 1,254,000,000 | 6.03% | 0.00% |
| Dec. 13, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 181 | $0.00 | 37,259.0000 | 1,262,000,000 | 0.49% | 0.00% |
| Dec. 13, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 157 | $0.00 | 37,533.0000 | 1,254,000,000 | 0.42% | 0.00% |
| Dec. 13, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 298 | $83.09 | 37,235.0000 | 1,262,000,000 | 0.79% | 0.00% |
| Dec. 13, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 157 | $91.86 | 37,078.0000 | 1,254,000,000 | 0.42% | 0.00% |
| Dec. 13, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 181 | $0.00 | 12,101.0000 | 1,262,000,000 | 1.47% | 0.00% |
| Dec. 13, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 117 | $0.00 | 11,984.0000 | 1,262,000,000 | 0.97% | 0.00% |
| Dec. 13, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 157 | $0.00 | 11,827.0000 | 1,254,000,000 | 1.31% | 0.00% |
| Dec. 13, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 117 | $0.00 | 37,376.0000 | 1,262,000,000 | 0.31% | 0.00% |
| Dec. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10295 | $0.00 | 506,290.0000 | 1,254,000,000 | 2.08% | 0.00% |
| Dec. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4762 | $92.34 | 501,528.0000 | 1,254,000,000 | 0.94% | 0.00% |
| Dec. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10295 | $0.00 | 104,977.0000 | 1,254,000,000 | 8.93% | 0.00% |
| Dec. 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3752 | $0.00 | 76,879.0000 | 1,254,000,000 | 5.13% | 0.00% |
| Dec. 10, 2024 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1739 | $92.34 | 75,140.0000 | 1,254,000,000 | 2.26% | 0.00% |
| Dec. 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3752 | $0.00 | 36,193.0000 | 1,254,000,000 | 9.39% | 0.00% |
| Dec. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3640 | $0.00 | 142,559.0000 | 1,254,000,000 | 2.62% | 0.00% |
| Dec. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1686 | $92.34 | 140,873.0000 | 1,254,000,000 | 1.18% | 0.00% |
| Dec. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3640 | $0.00 | 35,487.0000 | 1,254,000,000 | 9.30% | 0.00% |
| Dec. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 639 | $0.00 | 21,618.0000 | 1,254,000,000 | 3.05% | 0.00% |
| Dec. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 306 | $92.34 | 21,312.0000 | 1,254,000,000 | 1.42% | 0.00% |
| Dec. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 639 | $0.00 | 28,394.0000 | 1,254,000,000 | 2.20% | 0.00% |
| Dec. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 901 | $0.00 | 37,486.0000 | 1,254,000,000 | 2.46% | 0.00% |
| Dec. 10, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 408 | $92.34 | 37,078.0000 | 1,254,000,000 | 1.09% | 0.00% |
| Dec. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 901 | $0.00 | 12,282.0000 | 1,254,000,000 | 6.83% | 0.00% |
| Dec. 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3820 | $0.00 | 84,621.0000 | 1,254,000,000 | 4.73% | 0.00% |
| Dec. 10, 2024 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1771 | $92.34 | 82,850.0000 | 1,254,000,000 | 2.09% | 0.00% |
| Dec. 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3820 | $0.00 | 36,753.0000 | 1,254,000,000 | 9.42% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 18630 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 33660 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 60885 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 43340 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 65960 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.01% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 18630 | $73.77 | 157,549.0000 | 1,254,000,000 | 13.41% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 26170 | $57.92 | 183,719.0000 | 1,254,000,000 | 16.61% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 33660 | $68.75 | 217,379.0000 | 1,254,000,000 | 18.32% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 60885 | $71.91 | 278,264.0000 | 1,254,000,000 | 28.01% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 43340 | $72.70 | 321,604.0000 | 1,254,000,000 | 15.58% | 0.00% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 65960 | $72.70 | 387,564.0000 | 1,254,000,000 | 20.51% | 0.01% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 120715 | $92.77 | 266,849.0000 | 1,254,000,000 | 31.15% | 0.01% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 127930 | $92.76 | 138,919.0000 | 1,254,000,000 | 47.94% | 0.01% |
| Nov. 29, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Non-qualified Stock Option (Right to Buy) | 26170 | $0.00 | 130,860.0000 | 1,254,000,000 | 16.67% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 88119 | $0.00 | 196.0000 | 1,254,000,000 | 99.78% | 0.01% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 88119 | $92.00 | 99,599.0000 | 1,254,000,000 | 46.94% | 0.01% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 5200 | $91.80 | 94,399.0000 | 1,254,000,000 | 5.22% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 3199 | $91.80 | 91,200.0000 | 1,254,000,000 | 3.39% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 10399 | $92.00 | 80,801.0000 | 1,254,000,000 | 11.40% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 57294 | $0.00 | 64,376.0000 | 1,254,000,000 | 47.09% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 57294 | $57.92 | 156,893.0000 | 1,254,000,000 | 57.52% | 0.00% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 88119 | $65.38 | 245,012.0000 | 1,254,000,000 | 56.17% | 0.01% |
| Nov. 27, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 57294 | $91.79 | 187,718.0000 | 1,254,000,000 | 23.38% | 0.00% |
| Nov. 26, 2024 | Bluestone Jeffrey | Director | M | Common Stock | 4121 | $61.35 | 15,708.0000 | 1,254,000,000 | 35.57% | 0.00% |
| Nov. 26, 2024 | Bluestone Jeffrey | Director | S | Common Stock | 6788 | $91.39 | 8,920.0000 | 1,254,000,000 | 43.21% | 0.00% |
| Nov. 26, 2024 | Bluestone Jeffrey | Director | M | Non-qualified Stock Option (Right to Buy) | 5879 | $0.00 | 0.0000 | 1,254,000,000 | 100.00% | 0.00% |
| Nov. 26, 2024 | Bluestone Jeffrey | Director | M | Non-qualified Stock Option (Right to Buy) | 4121 | $0.00 | 11,730.0000 | 1,254,000,000 | 26.00% | 0.00% |
| Nov. 26, 2024 | Bluestone Jeffrey | Director | M | Common Stock | 5879 | $61.17 | 11,587.0000 | 1,254,000,000 | 103.00% | 0.00% |
| Nov. 6, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 5000 | $91.50 | 99,599.0000 | 1,254,000,000 | 4.78% | 0.00% |
| Nov. 6, 2024 | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 121,670.0000 | 1,254,000,000 | 17.05% | 0.00% |
| Nov. 6, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 20590 | $91.50 | 104,599.0000 | 1,254,000,000 | 16.45% | 0.00% |
| Nov. 6, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 25000 | $57.92 | 125,189.0000 | 1,254,000,000 | 24.95% | 0.00% |
| Nov. 6, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 5000 | $91.28 | 73,127.0000 | 1,254,000,000 | 6.40% | 0.00% |
| Oct. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 29,033.0000 | 1,254,000,000 | 1.74% | 0.00% |
| Oct. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 21,221.0000 | 1,254,000,000 | 2.48% | 0.00% |
| Oct. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 242 | $89.00 | 20,979.0000 | 1,254,000,000 | 1.14% | 0.00% |
| Oct. 1, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $83.83 | 100,189.0000 | 1,254,000,000 | 1.96% | 0.00% |
| Sept. 12, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 15925 | $84.23 | 91,559.0000 | 1,258,000,000 | 14.82% | 0.00% |
| Sept. 12, 2024 | Parsey Merdad | Chief Medical Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 146,670.0000 | 1,258,000,000 | 14.56% | 0.00% |
| Sept. 12, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 25000 | $57.92 | 123,435.0000 | 1,258,000,000 | 25.40% | 0.00% |
| Sept. 12, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 21246 | $84.50 | 102,189.0000 | 1,258,000,000 | 17.21% | 0.00% |
| Sept. 12, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 13432 | $83.25 | 78,127.0000 | 1,258,000,000 | 14.67% | 0.00% |
| Sept. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1682 | $81.44 | 138,919.0000 | 1,258,000,000 | 1.20% | 0.00% |
| Sept. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3641 | $0.00 | 39,127.0000 | 1,258,000,000 | 8.51% | 0.00% |
| Sept. 10, 2024 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1766 | $81.44 | 98,435.0000 | 1,258,000,000 | 1.76% | 0.00% |
| Sept. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4749 | $81.44 | 495,995.0000 | 1,258,000,000 | 0.95% | 0.00% |
| Sept. 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3821 | $0.00 | 40,573.0000 | 1,258,000,000 | 8.61% | 0.00% |
| Sept. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10295 | $0.00 | 500,744.0000 | 1,258,000,000 | 2.10% | 0.00% |
| Sept. 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10295 | $0.00 | 115,272.0000 | 1,258,000,000 | 8.20% | 0.00% |
| Sept. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 639 | $0.00 | 21,014.0000 | 1,258,000,000 | 3.14% | 0.00% |
| Sept. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 307 | $81.44 | 20,707.0000 | 1,258,000,000 | 1.46% | 0.00% |
| Sept. 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 639 | $0.00 | 29,547.0000 | 1,258,000,000 | 2.12% | 0.00% |
| Sept. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 901 | $0.00 | 36,877.0000 | 1,258,000,000 | 2.50% | 0.00% |
| Sept. 10, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 292 | $81.44 | 36,585.0000 | 1,258,000,000 | 0.79% | 0.00% |
| Sept. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 901 | $0.00 | 13,183.0000 | 1,258,000,000 | 6.40% | 0.00% |
| Sept. 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3821 | $0.00 | 100,201.0000 | 1,258,000,000 | 3.96% | 0.00% |
| Sept. 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3641 | $0.00 | 140,601.0000 | 1,258,000,000 | 2.66% | 0.00% |
| Sept. 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3752 | $0.00 | 39,945.0000 | 1,258,000,000 | 8.59% | 0.00% |
| Sept. 10, 2024 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1734 | $81.44 | 107,484.0000 | 1,258,000,000 | 1.59% | 0.00% |
| Sept. 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3752 | $0.00 | 109,218.0000 | 1,258,000,000 | 3.56% | 0.00% |
| Aug. 28, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 9513 | $78.03 | 105,466.0000 | 1,258,000,000 | 8.27% | 0.00% |
| Aug. 13, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 5490 | $73.98 | 114,979.0000 | 1,258,000,000 | 4.56% | 0.00% |
| Aug. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 3678 | $0.00 | 36,956.0000 | 1,258,000,000 | 11.05% | 0.00% |
| Aug. 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 3678 | $0.00 | 14,084.0000 | 1,258,000,000 | 20.71% | 0.00% |
| Aug. 10, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 980 | $73.66 | 35,976.0000 | 1,258,000,000 | 2.65% | 0.00% |
| July 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8230 | $0.00 | 20,375.0000 | 1,258,000,000 | 67.76% | 0.00% |
| July 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 12,145.0000 | 1,258,000,000 | 4.42% | 0.00% |
| July 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 2917 | $76.51 | 11,631.0000 | 1,258,000,000 | 20.05% | 0.00% |
| July 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 38,416.0000 | 1,258,000,000 | 1.32% | 0.00% |
| July 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8230 | $0.00 | 30,186.0000 | 1,258,000,000 | 21.42% | 0.00% |
| July 1, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $68.63 | 96,380.0000 | 1,258,000,000 | 2.03% | 0.00% |
| June 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 204 | $65.25 | 14,548.0000 | 1,258,000,000 | 1.38% | 0.00% |
| June 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 638 | $0.00 | 38,930.0000 | 1,258,000,000 | 1.61% | 0.00% |
| June 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3639 | $0.00 | 138,622.0000 | 1,258,000,000 | 2.70% | 0.00% |
| June 10, 2024 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1662 | $65.25 | 136,960.0000 | 1,258,000,000 | 1.20% | 0.00% |
| June 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3639 | $0.00 | 42,768.0000 | 1,258,000,000 | 7.84% | 0.00% |
| June 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 901 | $0.00 | 33,533.0000 | 1,258,000,000 | 2.76% | 0.00% |
| June 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 901 | $0.00 | 17,762.0000 | 1,258,000,000 | 4.83% | 0.00% |
| June 10, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 255 | $65.25 | 33,278.0000 | 1,258,000,000 | 0.76% | 0.00% |
| June 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10295 | $0.00 | 495,142.0000 | 1,258,000,000 | 2.12% | 0.00% |
| June 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4693 | $65.25 | 490,449.0000 | 1,258,000,000 | 0.95% | 0.00% |
| June 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10295 | $0.00 | 125,567.0000 | 1,258,000,000 | 7.58% | 0.00% |
| June 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3751 | $0.00 | 122,183.0000 | 1,258,000,000 | 3.17% | 0.00% |
| June 10, 2024 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1714 | $65.25 | 120,469.0000 | 1,258,000,000 | 1.40% | 0.00% |
| June 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3751 | $0.00 | 43,697.0000 | 1,258,000,000 | 7.91% | 0.00% |
| June 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3820 | $0.00 | 100,124.0000 | 1,258,000,000 | 3.97% | 0.00% |
| June 10, 2024 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1744 | $65.25 | 98,380.0000 | 1,258,000,000 | 1.74% | 0.00% |
| June 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3820 | $0.00 | 44,394.0000 | 1,258,000,000 | 7.92% | 0.00% |
| June 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 638 | $0.00 | 14,752.0000 | 1,258,000,000 | 4.52% | 0.00% |
| May 8, 2024 | BARTON JACQUELINE K | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | BARTON JACQUELINE K | Director | A | Common Stock | 2310 | $0.00 | 24,540.0000 | 1,258,000,000 | 10.39% | 0.00% |
| May 8, 2024 | LOVE TED W | Director | A | Common Stock | 2310 | $0.00 | 2,822.0000 | 1,258,000,000 | 451.17% | 0.00% |
| May 8, 2024 | LOVE TED W | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | Rodriguez Javier | Director | A | Common Stock | 2310 | $0.00 | 10,702.0000 | 1,258,000,000 | 27.53% | 0.00% |
| May 8, 2024 | Rodriguez Javier | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | WELTERS ANTHONY | Director | A | Common Stock | 2310 | $0.00 | 10,232.0000 | 1,258,000,000 | 29.16% | 0.00% |
| May 8, 2024 | WELTERS ANTHONY | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | MANWANI HARISH | Director | A | Common Stock | 2310 | $0.00 | 13,324.0000 | 1,258,000,000 | 20.97% | 0.00% |
| May 8, 2024 | MANWANI HARISH | Director | F | Common Stock | 451 | $64.92 | 12,873.0000 | 1,258,000,000 | 3.38% | 0.00% |
| May 8, 2024 | MANWANI HARISH | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | Bluestone Jeffrey | Director | A | Restricted Stock Unit | 2310 | $0.00 | 4,197.0000 | 1,258,000,000 | 122.42% | 0.00% |
| May 8, 2024 | Bluestone Jeffrey | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | Horning Sandra | Director | A | Restricted Stock Unit | 2310 | $0.00 | 7,801.0000 | 1,258,000,000 | 42.07% | 0.00% |
| May 8, 2024 | Horning Sandra | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| May 8, 2024 | Kramer Kelly A. | Director | A | Restricted Stock Unit | 2310 | $0.00 | 17,594.0000 | 1,258,000,000 | 15.11% | 0.00% |
| May 8, 2024 | Kramer Kelly A. | Director | A | Non-qualified Stock Option (Right to Buy) | 12648 | $0.00 | 12,648.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| April 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 14,272.0000 | 1,258,000,000 | 3.74% | 0.00% |
| April 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 39,568.0000 | 1,258,000,000 | 1.28% | 0.00% |
| April 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 158 | $65.27 | 14,114.0000 | 1,258,000,000 | 1.11% | 0.00% |
| April 2, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Prefunded Warrants (right to buy) | 3882450 | $0.76 | 3,882,450.0000 | 1,258,000,000 | 9999.99% | 0.31% |
| April 2, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 485250 | $0.76 | 7,345,473.0000 | 1,258,000,000 | 7.07% | 0.04% |
| April 1, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $72.96 | 96,304.0000 | 1,258,000,000 | 2.03% | 0.00% |
| March 28, 2024 | Lofton Kevin E | Director | A | Phantom Stock | 34 | $0.00 | 3,258.1388 | 1,258,000,000 | 1.05% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 748 | $0.00 | 31,488.0000 | 1,258,000,000 | 2.43% | 0.00% |
| March 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 10815 | $0.00 | 40,083.0000 | 1,258,000,000 | 36.95% | 0.00% |
| March 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 54980 | $0.00 | 54,980.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 2555 | $0.00 | 29,268.0000 | 1,258,000,000 | 8.03% | 0.00% |
| March 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 846 | $75.12 | 13,757.0000 | 1,258,000,000 | 5.79% | 0.00% |
| March 10, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 2555 | $0.00 | 14,603.0000 | 1,258,000,000 | 21.21% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | A | Restricted Stock Unit | 4825 | $0.00 | 18,663.0000 | 1,258,000,000 | 34.87% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 1934 | $0.00 | 13,838.0000 | 1,258,000,000 | 12.26% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | A | Non-qualified Stock Option (Right to Buy) | 13660 | $0.00 | 13,660.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 748 | $0.00 | 15,772.0000 | 1,258,000,000 | 4.53% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | F | Common Stock | 790 | $75.12 | 32,632.0000 | 1,258,000,000 | 2.36% | 0.00% |
| March 10, 2024 | Patterson Sandra | SVP, Controllership | M | Common Stock | 1934 | $0.00 | 33,422.0000 | 1,258,000,000 | 6.14% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 6819 | $0.00 | 30,143.0000 | 1,258,000,000 | 18.45% | 0.00% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3025 | $0.00 | 132,781.0000 | 1,258,000,000 | 2.33% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 17305 | $0.00 | 47,448.0000 | 1,258,000,000 | 57.41% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3455 | $0.00 | 96,161.0000 | 1,258,000,000 | 3.73% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 6946 | $0.00 | 103,107.0000 | 1,258,000,000 | 7.22% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 4803 | $75.12 | 98,304.0000 | 1,258,000,000 | 4.66% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3455 | $0.00 | 37,520.0000 | 1,258,000,000 | 8.43% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 6946 | $0.00 | 30,574.0000 | 1,258,000,000 | 18.51% | 0.00% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 89660 | $0.00 | 89,660.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| March 10, 2024 | Parsey Merdad | Chief Medical Officer | A | Restricted Stock Unit | 17640 | $0.00 | 48,214.0000 | 1,258,000,000 | 57.70% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10800 | $0.00 | 479,489.0000 | 1,258,000,000 | 2.30% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 19140 | $0.00 | 498,629.0000 | 1,258,000,000 | 3.99% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 13782 | $75.12 | 484,847.0000 | 1,258,000,000 | 2.76% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10800 | $0.00 | 100,092.0000 | 1,258,000,000 | 9.74% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 19140 | $0.00 | 80,952.0000 | 1,258,000,000 | 19.12% | 0.00% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | A | Non-qualified Stock Option (Right to Buy) | 279130 | $0.00 | 279,130.0000 | 1,258,000,000 | 9999.99% | 0.02% |
| March 10, 2024 | O'Day Daniel Patrick | Chairman & CEO | A | Restricted Stock Unit | 54910 | $0.00 | 135,862.0000 | 1,258,000,000 | 67.83% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3025 | $0.00 | 116,172.0000 | 1,258,000,000 | 2.67% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 6819 | $0.00 | 122,991.0000 | 1,258,000,000 | 5.87% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 4559 | $75.12 | 118,432.0000 | 1,258,000,000 | 3.71% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 36,962.0000 | 1,258,000,000 | 7.56% | 0.00% |
| March 10, 2024 | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 87970 | $0.00 | 87,970.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 17305 | $0.00 | 46,407.0000 | 1,258,000,000 | 59.46% | 0.00% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 87970 | $0.00 | 87,970.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 6707 | $0.00 | 28,333.0000 | 1,258,000,000 | 19.14% | 0.00% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 35,040.0000 | 1,258,000,000 | 7.95% | 0.00% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 4505 | $75.12 | 134,983.0000 | 1,258,000,000 | 3.23% | 0.00% |
| March 10, 2024 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 6707 | $0.00 | 139,488.0000 | 1,258,000,000 | 5.05% | 0.00% |
| Feb. 29, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 8230 | $72.74 | 92,706.0000 | 1,258,000,000 | 8.15% | 0.00% |
| Feb. 28, 2024 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 2000 | $73.18 | 100,936.0000 | 1,258,000,000 | 1.94% | 0.00% |
| Feb. 2, 2024 | LOVE TED W | Director | A | Common Stock | 512 | $0.00 | 512.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| Feb. 2, 2024 | LOVE TED W | Director | A | Non-qualified Stock Option (Right to Buy) | 2996 | $0.00 | 2,996.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 50870 | $0.00 | 368,147.0000 | 1,258,000,000 | 16.03% | 0.00% |
| Jan. 31, 2024 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 79335 | $78.26 | 468,689.0000 | 1,258,000,000 | 14.48% | 0.01% |
| Jan. 31, 2024 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 22509 | $78.26 | 113,147.0000 | 1,258,000,000 | 16.59% | 0.00% |
| Jan. 31, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 4646 | $0.00 | 11,728.0000 | 1,258,000,000 | 65.60% | 0.00% |
| Jan. 31, 2024 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 19006 | $0.00 | 96,891.0000 | 1,258,000,000 | 24.40% | 0.00% |
| Jan. 31, 2024 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 179877 | $0.00 | 548,024.0000 | 1,258,000,000 | 48.86% | 0.01% |
| Jan. 31, 2024 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 23410 | $78.26 | 129,436.0000 | 1,258,000,000 | 15.32% | 0.00% |
| Jan. 31, 2024 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 55955 | $0.00 | 152,846.0000 | 1,258,000,000 | 57.75% | 0.00% |
| Jan. 31, 2024 | Parsey Merdad | Chief Medical Officer | A | Common Stock | 20229 | $0.00 | 69,701.0000 | 1,258,000,000 | 40.89% | 0.00% |
| Jan. 31, 2024 | Parsey Merdad | Chief Medical Officer | A | Common Stock | 56624 | $0.00 | 126,325.0000 | 1,258,000,000 | 81.24% | 0.00% |
| Jan. 31, 2024 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 23709 | $78.26 | 102,616.0000 | 1,258,000,000 | 18.77% | 0.00% |
| Jan. 31, 2024 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 20086 | $0.00 | 81,687.0000 | 1,258,000,000 | 32.61% | 0.00% |
| Jan. 31, 2024 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 53969 | $0.00 | 135,656.0000 | 1,258,000,000 | 66.07% | 0.00% |
| Jan. 29, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 15238095 | $21.00 | 30,061,124.0000 | 1,258,000,000 | 102.80% | 1.21% |
| Jan. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 7,276.0000 | 1,258,000,000 | 7.60% | 0.00% |
| Jan. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 194 | $80.23 | 7,082.0000 | 1,258,000,000 | 2.67% | 0.00% |
| Jan. 25, 2024 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 31,823.0000 | 1,258,000,000 | 1.59% | 0.00% |
| Jan. 16, 2024 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $85.78 | 101,534.0000 | 1,258,000,000 | 4.69% | 0.00% |
| Jan. 9, 2024 | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 8242 | $85.23 | 82,729.0000 | 1,258,000,000 | 9.06% | 0.00% |
| Dec. 28, 2023 | Lofton Kevin E | Director | A | Phantom Stock | 30 | $0.00 | 3,224.2457 | 1,262,000,000 | 0.92% | 0.00% |
| Dec. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1194 | $79.02 | 106,534.0000 | 1,262,000,000 | 1.11% | 0.00% |
| Dec. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2617 | $0.00 | 107,728.0000 | 1,262,000,000 | 2.49% | 0.00% |
| Dec. 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 92,218.0000 | 1,262,000,000 | 3.05% | 0.00% |
| Dec. 10, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1247 | $79.02 | 90,971.0000 | 1,262,000,000 | 1.35% | 0.00% |
| Dec. 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 39,987.0000 | 1,262,000,000 | 6.39% | 0.00% |
| Dec. 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 72,909.0000 | 1,262,000,000 | 3.96% | 0.00% |
| Dec. 10, 2023 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1269 | $79.02 | 71,640.0000 | 1,262,000,000 | 1.74% | 0.00% |
| Dec. 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 40,975.0000 | 1,262,000,000 | 6.35% | 0.00% |
| Dec. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 518 | $0.00 | 30,642.0000 | 1,262,000,000 | 1.72% | 0.00% |
| Dec. 10, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 222 | $79.02 | 30,420.0000 | 1,262,000,000 | 0.72% | 0.00% |
| Dec. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 518 | $0.00 | 16,520.0000 | 1,262,000,000 | 3.04% | 0.00% |
| Dec. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2617 | $0.00 | 38,834.0000 | 1,262,000,000 | 6.31% | 0.00% |
| Dec. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 3341 | $79.02 | 387,691.0000 | 1,262,000,000 | 0.85% | 0.00% |
| Dec. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 7347 | $0.00 | 391,032.0000 | 1,262,000,000 | 1.91% | 0.00% |
| Dec. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 7347 | $0.00 | 110,892.0000 | 1,262,000,000 | 6.21% | 0.00% |
| Nov. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 804 | $75.92 | 105,111.0000 | 1,262,000,000 | 0.76% | 0.00% |
| Nov. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 1912 | $0.00 | 41,451.0000 | 1,262,000,000 | 4.41% | 0.00% |
| Nov. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 1912 | $0.00 | 105,915.0000 | 1,262,000,000 | 1.84% | 0.00% |
| Oct. 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 243 | $78.39 | 6,762.0000 | 1,262,000,000 | 3.47% | 0.00% |
| Oct. 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 32,337.0000 | 1,262,000,000 | 1.56% | 0.00% |
| Oct. 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 7,005.0000 | 1,262,000,000 | 7.92% | 0.00% |
| Oct. 17, 2023 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $80.00 | 104,003.0000 | 1,262,000,000 | 4.59% | 0.00% |
| Sept. 28, 2023 | Lofton Kevin E | Director | A | Phantom Stock | 31 | $0.00 | 3,194.7161 | 1,262,000,000 | 0.99% | 0.00% |
| Sept. 12, 2023 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 1501 | $76.99 | 70,130.0000 | 1,262,000,000 | 2.10% | 0.00% |
| Sept. 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 90,744.0000 | 1,262,000,000 | 3.10% | 0.00% |
| Sept. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 7348 | $0.00 | 118,239.0000 | 1,262,000,000 | 5.85% | 0.00% |
| Sept. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 3366 | $76.00 | 383,685.0000 | 1,262,000,000 | 0.87% | 0.00% |
| Sept. 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 7348 | $0.00 | 387,051.0000 | 1,262,000,000 | 1.94% | 0.00% |
| Sept. 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 43,754.0000 | 1,262,000,000 | 5.97% | 0.00% |
| Sept. 10, 2023 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1278 | $76.00 | 71,631.0000 | 1,262,000,000 | 1.75% | 0.00% |
| Sept. 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 72,909.0000 | 1,262,000,000 | 3.96% | 0.00% |
| Sept. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 519 | $0.00 | 17,038.0000 | 1,262,000,000 | 2.96% | 0.00% |
| Sept. 10, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 149 | $76.00 | 30,124.0000 | 1,262,000,000 | 0.49% | 0.00% |
| Sept. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 519 | $0.00 | 30,273.0000 | 1,262,000,000 | 1.74% | 0.00% |
| Sept. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2619 | $0.00 | 43,363.0000 | 1,262,000,000 | 5.70% | 0.00% |
| Sept. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1203 | $76.00 | 109,003.0000 | 1,262,000,000 | 1.09% | 0.00% |
| Sept. 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2619 | $0.00 | 110,206.0000 | 1,262,000,000 | 2.43% | 0.00% |
| Sept. 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 42,717.0000 | 1,262,000,000 | 6.01% | 0.00% |
| Sept. 10, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1256 | $76.00 | 89,488.0000 | 1,262,000,000 | 1.38% | 0.00% |
| Aug. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 4484 | $0.00 | 31,060.0000 | 1,262,000,000 | 16.87% | 0.00% |
| Aug. 10, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 1306 | $80.00 | 29,754.0000 | 1,262,000,000 | 4.20% | 0.00% |
| Aug. 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 4484 | $0.00 | 17,557.0000 | 1,262,000,000 | 20.34% | 0.00% |
| July 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8231 | $0.00 | 34,909.0000 | 1,262,000,000 | 19.08% | 0.00% |
| July 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8231 | $0.00 | 8,607.0000 | 1,262,000,000 | 2189.10% | 0.00% |
| July 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 4174 | $77.23 | 4,433.0000 | 1,262,000,000 | 48.50% | 0.00% |
| July 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 2058 | $0.00 | 6,491.0000 | 1,262,000,000 | 46.42% | 0.00% |
| July 25, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 2058 | $0.00 | 32,851.0000 | 1,262,000,000 | 5.90% | 0.00% |
| July 24, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 7505 | $0.00 | 51,500.0000 | 1,262,000,000 | 17.06% | 0.00% |
| July 24, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 3174 | $77.66 | 48,326.0000 | 1,262,000,000 | 6.16% | 0.00% |
| July 24, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 7505 | $0.00 | 45,447.0000 | 1,262,000,000 | 14.17% | 0.00% |
| July 20, 2023 | Dickinson Andrew D | Chief Financial Officer | S | Common Stock | 5000 | $80.00 | 107,587.0000 | 1,262,000,000 | 4.44% | 0.00% |
| June 28, 2023 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 1010000 | $19.26 | 14,823,029.0000 | 1,262,000,000 | 7.31% | 0.08% |
| June 29, 2023 | Lofton Kevin E | Director | A | Phantom Stock | 31 | $0.00 | 3,163.2596 | 1,262,000,000 | 0.99% | 0.00% |
| June 27, 2023 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 2930870 | $3.75 | 16,635,286.0000 | 1,262,000,000 | 21.39% | 0.23% |
| June 13, 2023 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 1485 | $76.90 | 29,402.0000 | 1,262,000,000 | 4.81% | 0.00% |
| June 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 517 | $0.00 | 26,729.0000 | 1,262,000,000 | 1.97% | 0.00% |
| June 10, 2023 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 1294 | $78.12 | 30,887.0000 | 1,262,000,000 | 4.02% | 0.00% |
| June 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 2779 | $0.00 | 32,181.0000 | 1,262,000,000 | 9.45% | 0.00% |
| June 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 517 | $0.00 | 22,041.0000 | 1,262,000,000 | 2.29% | 0.00% |
| June 10, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 153 | $78.12 | 26,576.0000 | 1,262,000,000 | 0.57% | 0.00% |
| June 10, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 1219 | $78.12 | 73,701.0000 | 1,262,000,000 | 1.63% | 0.00% |
| June 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 2618 | $0.00 | 74,920.0000 | 1,262,000,000 | 3.62% | 0.00% |
| June 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 2618 | $0.00 | 45,982.0000 | 1,262,000,000 | 5.39% | 0.00% |
| June 10, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1272 | $78.12 | 43,995.0000 | 1,262,000,000 | 2.81% | 0.00% |
| June 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 52,952.0000 | 1,262,000,000 | 4.90% | 0.00% |
| June 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 45,267.0000 | 1,262,000,000 | 6.42% | 0.00% |
| June 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 7346 | $0.00 | 125,587.0000 | 1,262,000,000 | 5.53% | 0.00% |
| June 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 3409 | $78.12 | 266,125.0000 | 1,262,000,000 | 1.26% | 0.00% |
| June 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 7346 | $0.00 | 269,534.0000 | 1,262,000,000 | 2.80% | 0.00% |
| June 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 2779 | $0.00 | 46,533.0000 | 1,262,000,000 | 5.64% | 0.00% |
| May 3, 2023 | MANWANI HARISH | Director | A | Common Stock | 1887 | $0.00 | 11,382.0000 | 1,262,000,000 | 19.87% | 0.00% |
| May 3, 2023 | Kramer Kelly A. | Director | A | Restricted Stock Unit | 1887 | $0.00 | 15,284.0000 | 1,262,000,000 | 14.09% | 0.00% |
| May 3, 2023 | Horning Sandra | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Kramer Kelly A. | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | BARTON JACQUELINE K | Director | A | Common Stock | 1887 | $0.00 | 22,230.0000 | 1,262,000,000 | 9.28% | 0.00% |
| May 3, 2023 | BARTON JACQUELINE K | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Bluestone Jeffrey | Director | A | Restricted Stock Unit | 1887 | $0.00 | 1,887.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Bluestone Jeffrey | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | WELTERS ANTHONY | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | WELTERS ANTHONY | Director | A | Common Stock | 1887 | $0.00 | 7,922.0000 | 1,262,000,000 | 31.27% | 0.00% |
| May 3, 2023 | MANWANI HARISH | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | MANWANI HARISH | Director | F | Common Stock | 368 | $79.45 | 11,014.0000 | 1,262,000,000 | 3.23% | 0.00% |
| May 3, 2023 | Rodriguez Javier | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Rodriguez Javier | Director | A | Common Stock | 1887 | $0.00 | 8,392.0000 | 1,262,000,000 | 29.01% | 0.00% |
| May 3, 2023 | Lofton Kevin E | Director | A | Non-qualified Stock Option (Right to Buy) | 10173 | $79.45 | 10,173.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Lofton Kevin E | Director | A | Common Stock | 1887 | $0.00 | 92,653.0000 | 1,262,000,000 | 2.08% | 0.00% |
| May 3, 2023 | Horning Sandra | Director | A | Common Stock | 1887 | $0.00 | 3,631.0000 | 1,262,000,000 | 108.20% | 0.00% |
| May 1, 2023 | Lofton Kevin E | Director | G | Common Stock | 12868 | $0.00 | 90,766.0000 | 1,262,000,000 | 12.42% | 0.00% |
| March 30, 2023 | Lofton Kevin E | Director | A | Phantom Stock | 29 | $0.00 | 3,132.3523 | 1,262,000,000 | 0.92% | 0.00% |
| March 13, 2023 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 6126 | $78.99 | 70,130.0000 | 1,262,000,000 | 8.03% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 19488 | $0.00 | 378,983.0000 | 1,262,000,000 | 5.42% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 10800 | $0.00 | 389,783.0000 | 1,262,000,000 | 2.85% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 14017 | $79.50 | 375,766.0000 | 1,262,000,000 | 3.60% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 19488 | $0.00 | 96,563.0000 | 1,262,000,000 | 16.79% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 10800 | $0.00 | 85,763.0000 | 1,262,000,000 | 11.18% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | A | Restricted Stock Unit | 47170 | $0.00 | 132,933.0000 | 1,262,000,000 | 55.00% | 0.00% |
| March 10, 2023 | O'Day Daniel Patrick | Chairman & CEO | A | Non-qualified Stock Option (Right to Buy) | 215095 | $0.00 | 215,095.0000 | 1,262,000,000 | 9999.99% | 0.02% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | A | Restricted Stock Unit | 16665 | $0.00 | 49,312.0000 | 1,262,000,000 | 51.05% | 0.00% |
| March 10, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 46605 | $0.00 | 46,605.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| March 10, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 10220 | $0.00 | 43,140.0000 | 1,262,000,000 | 31.04% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 74565 | $0.00 | 74,565.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | A | Restricted Stock Unit | 16350 | $0.00 | 48,600.0000 | 1,262,000,000 | 50.70% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 7394 | $0.00 | 32,250.0000 | 1,262,000,000 | 18.65% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 39,644.0000 | 1,262,000,000 | 7.09% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 4849 | $79.50 | 111,188.0000 | 1,262,000,000 | 4.18% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 7394 | $0.00 | 116,037.0000 | 1,262,000,000 | 6.81% | 0.00% |
| March 10, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 3025 | $0.00 | 108,643.0000 | 1,262,000,000 | 2.86% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 74565 | $0.00 | 74,565.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 16350 | $0.00 | 55,682.0000 | 1,262,000,000 | 41.57% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 7951 | $0.00 | 39,332.0000 | 1,262,000,000 | 16.82% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 47,283.0000 | 1,262,000,000 | 6.01% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 5116 | $79.50 | 82,225.0000 | 1,262,000,000 | 5.86% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 7951 | $0.00 | 87,341.0000 | 1,262,000,000 | 10.02% | 0.00% |
| March 10, 2023 | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3025 | $0.00 | 79,390.0000 | 1,262,000,000 | 3.96% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | A | Non-qualified Stock Option (Right to Buy) | 10405 | $0.00 | 10,405.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | A | Restricted Stock Unit | 6130 | $0.00 | 22,558.0000 | 1,262,000,000 | 37.31% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 1320 | $0.00 | 16,428.0000 | 1,262,000,000 | 7.44% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | M | Restricted Stock Unit | 1601 | $0.00 | 17,748.0000 | 1,262,000,000 | 8.27% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | F | Common Stock | 801 | $79.50 | 26,212.0000 | 1,262,000,000 | 2.97% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 1320 | $0.00 | 27,013.0000 | 1,262,000,000 | 5.14% | 0.00% |
| March 10, 2023 | Patterson Sandra | SVP, Controllership | M | Common Stock | 1601 | $0.00 | 25,693.0000 | 1,262,000,000 | 6.65% | 0.00% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 7999 | $0.00 | 32,647.0000 | 1,262,000,000 | 19.68% | 0.00% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Restricted Stock Unit | 3455 | $0.00 | 40,646.0000 | 1,262,000,000 | 7.83% | 0.00% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 5328 | $79.50 | 76,256.0000 | 1,262,000,000 | 6.53% | 0.00% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 7999 | $0.00 | 81,584.0000 | 1,262,000,000 | 10.87% | 0.00% |
| March 10, 2023 | Parsey Merdad | Chief Medical Officer | M | Common Stock | 3455 | $0.00 | 73,585.0000 | 1,262,000,000 | 4.93% | 0.00% |
| March 9, 2023 | Lofton Kevin E | Director | M | Common Stock | 8442 | $52.38 | 103,634.0000 | 1,262,000,000 | 8.87% | 0.00% |
| March 9, 2023 | Lofton Kevin E | Director | M | Non-qualified Stock Option (Right to Buy) | 8442 | $0.00 | 0.0000 | 1,262,000,000 | 100.00% | 0.00% |
| March 1, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Restricted Stock Unit | 11362 | $0.00 | 116,051.0000 | 1,262,000,000 | 8.92% | 0.00% |
| March 1, 2023 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 12984 | $79.96 | 70,130.0000 | 1,262,000,000 | 15.62% | 0.00% |
| March 1, 2023 | O'Day Daniel Patrick | Chairman & CEO | M | Common Stock | 11362 | $0.00 | 364,337.0000 | 1,262,000,000 | 3.22% | 0.00% |
| March 1, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 4842 | $79.59 | 359,495.0000 | 1,262,000,000 | 1.33% | 0.00% |
| Feb. 15, 2023 | Parsey Merdad | Chief Medical Officer | A | Common Stock | 376 | $56.38 | 83,114.0000 | 1,262,000,000 | 0.45% | 0.00% |
| Feb. 15, 2023 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 376 | $56.38 | 105,618.0000 | 1,262,000,000 | 0.36% | 0.00% |
| Feb. 15, 2023 | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 376 | $56.38 | 376.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Wilfong Diane E. | SVP, Controller & CAO | M | Common Stock | 1864 | $0.00 | 32,575.0000 | 1,262,000,000 | 6.07% | 0.00% |
| Feb. 6, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Restricted Stock Unit | 1817 | $0.00 | 42,669.0000 | 1,262,000,000 | 4.08% | 0.00% |
| Feb. 6, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 531 | $86.36 | 105,242.0000 | 1,262,000,000 | 0.50% | 0.00% |
| Feb. 6, 2023 | Dickinson Andrew D | Chief Financial Officer | M | Common Stock | 1817 | $0.00 | 105,773.0000 | 1,262,000,000 | 1.75% | 0.00% |
| Feb. 6, 2023 | Wilfong Diane E. | SVP, Controller & CAO | M | Restricted Stock Unit | 1864 | $0.00 | 11,060.0000 | 1,262,000,000 | 14.42% | 0.00% |
| Feb. 6, 2023 | Wilfong Diane E. | SVP, Controller & CAO | F | Common Stock | 565 | $86.36 | 32,010.0000 | 1,262,000,000 | 1.73% | 0.00% |
| Jan. 24, 2023 | Parsey Merdad | Chief Medical Officer | A | Common Stock | 43715 | $0.00 | 100,487.0000 | 1,262,000,000 | 77.00% | 0.00% |
| Jan. 24, 2023 | O'Day Daniel Patrick | Chairman & CEO | F | Common Stock | 59078 | $84.02 | 352,975.0000 | 1,262,000,000 | 14.34% | 0.00% |
| Jan. 24, 2023 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 136647 | $0.00 | 412,053.0000 | 1,262,000,000 | 49.62% | 0.01% |
| Jan. 24, 2023 | O'Day Daniel Patrick | Chairman & CEO | A | Common Stock | 78370 | $0.00 | 275,406.0000 | 1,262,000,000 | 39.77% | 0.01% |
| Jan. 24, 2023 | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 15325 | $84.02 | 76,365.0000 | 1,262,000,000 | 16.71% | 0.00% |
| Jan. 24, 2023 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 38270 | $0.00 | 91,690.0000 | 1,262,000,000 | 71.64% | 0.00% |
| Jan. 24, 2023 | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 29124 | $0.00 | 53,420.0000 | 1,262,000,000 | 119.87% | 0.00% |
| Jan. 24, 2023 | Dickinson Andrew D | Chief Financial Officer | F | Common Stock | 15327 | $84.02 | 103,956.0000 | 1,262,000,000 | 12.85% | 0.00% |
| Jan. 24, 2023 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 38270 | $0.00 | 119,283.0000 | 1,262,000,000 | 47.24% | 0.00% |
| Jan. 24, 2023 | Dickinson Andrew D | Chief Financial Officer | A | Common Stock | 27932 | $0.00 | 81,013.0000 | 1,262,000,000 | 52.62% | 0.00% |
| Jan. 24, 2023 | Parsey Merdad | Chief Medical Officer | A | Common Stock | 29644 | $0.00 | 56,772.0000 | 1,262,000,000 | 109.27% | 0.00% |
| Jan. 24, 2023 | Wilfong Diane E. | SVP, Controller & CAO | F | Common Stock | 1244 | $84.02 | 30,711.0000 | 1,262,000,000 | 3.89% | 0.00% |
| Jan. 24, 2023 | Wilfong Diane E. | SVP, Controller & CAO | A | Common Stock | 4100 | $0.00 | 31,955.0000 | 1,262,000,000 | 14.72% | 0.00% |
| Jan. 24, 2023 | Wilfong Diane E. | SVP, Controller & CAO | A | Common Stock | 1784 | $0.00 | 27,855.0000 | 1,262,000,000 | 6.84% | 0.00% |
| Jan. 24, 2023 | Parsey Merdad | Chief Medical Officer | F | Common Stock | 17749 | $84.02 | 82,738.0000 | 1,262,000,000 | 17.66% | 0.00% |
| Dec. 30, 2022 | Parsey Merdad | Chief Medical Officer | S | Common Stock | 553 | $85.33 | 45,556.0000 | 0 | 1.20% | 0.00% |